The growing interest in potent weight management has spurred considerable research into groundbreaking treatments. Lately , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor stimulator, has shown promising results in me